BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...Johnson & Johnson (NYSE:JNJ), the Canada Pension Plan Investment Board, TPG Biotech, OrbiMed Advisors and Seroba Life Sciences...
BioCentury | Jun 9, 2020
Finance

June 8 Financial Quick Takes: Novo’s REPAIR fund issues call for AMR proposals; B rounds for MabPlex, Clover; A rounds for Shorla, Curesponse

...spec pharma Shorla Pharma Ltd. has closed an $8.3 million series A round led by Seroba Life Sciences...
BioCentury | May 20, 2019
Financial News

May 20 Financial Quick Takes: Schrödinger tops off E round; plus Mabpharm IPO update, DNA Script, ADMA Biologics, Storm

...A round, now totaling £30 million ($38.3 million), to advance its preclinical pipeline. New investor Seroba Life Sciences...
BioCentury | Apr 2, 2019
Financial News

Fusion raises $105M series B for radiopharmaceutical pipeline

...existing investors HealthCap, Adams Street Partners, Johnson & Johnson Innovation -- JJDC Inc., TPG Biotech, Seroba Life Sciences...
BioCentury | Jun 7, 2018
Emerging Company Profile

Radio fusion

...Investors: Adams Street Partners, FACIT, Genesys Capital, HealthCap, Johnson & Johnson Innovation - JJDC Inc., Seroba Life Sciences...
BioCentury | Sep 29, 2017
Financial News

Fusion, IsoPlexis, Tempus announce venture financings

...a series A round, bringing the total to $46 million. New investors Adams Street Partners, Seroba Life Sciences...
BioCentury | Sep 25, 2017
Financial News

Venture roundup: Fusion, IsoPlexis, Tempus

...a series A round, bringing the total to $46 million. New investors Adams Street Partners, Seroba Life Sciences...
BioCentury | Feb 11, 2017
Finance

Seroba’s shift

...the demand for biotech assets from potential buyers. The firm announced the first close of Seroba Life Sciences...
...in 2009 at €75 million ($96.8 million). O’Connell declined to disclose returns. - Virginia Li Virginia Li Seroba Life Sciences...
BioCentury | Feb 10, 2017
Financial News

Seroba Life Sciences financial update

...Seroba Life Sciences (Dublin, Ireland) announced the first close of its third fund, Seroba Life Sciences Fund III...
...other life sciences companies in Ireland, the U.K. and elsewhere in Europe. Seroba Life Sciences, Dublin, Ireland Alex Himes Seroba Life Sciences...
BioCentury | Feb 10, 2017
Financial News

Prexton completes venture financing

...€29 million ($31.2 million) in a series B round co-led by Forbion Capital Partners and Seroba Life Sciences...
Items per page:
1 - 10 of 12
BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...Johnson & Johnson (NYSE:JNJ), the Canada Pension Plan Investment Board, TPG Biotech, OrbiMed Advisors and Seroba Life Sciences...
BioCentury | Jun 9, 2020
Finance

June 8 Financial Quick Takes: Novo’s REPAIR fund issues call for AMR proposals; B rounds for MabPlex, Clover; A rounds for Shorla, Curesponse

...spec pharma Shorla Pharma Ltd. has closed an $8.3 million series A round led by Seroba Life Sciences...
BioCentury | May 20, 2019
Financial News

May 20 Financial Quick Takes: Schrödinger tops off E round; plus Mabpharm IPO update, DNA Script, ADMA Biologics, Storm

...A round, now totaling £30 million ($38.3 million), to advance its preclinical pipeline. New investor Seroba Life Sciences...
BioCentury | Apr 2, 2019
Financial News

Fusion raises $105M series B for radiopharmaceutical pipeline

...existing investors HealthCap, Adams Street Partners, Johnson & Johnson Innovation -- JJDC Inc., TPG Biotech, Seroba Life Sciences...
BioCentury | Jun 7, 2018
Emerging Company Profile

Radio fusion

...Investors: Adams Street Partners, FACIT, Genesys Capital, HealthCap, Johnson & Johnson Innovation - JJDC Inc., Seroba Life Sciences...
BioCentury | Sep 29, 2017
Financial News

Fusion, IsoPlexis, Tempus announce venture financings

...a series A round, bringing the total to $46 million. New investors Adams Street Partners, Seroba Life Sciences...
BioCentury | Sep 25, 2017
Financial News

Venture roundup: Fusion, IsoPlexis, Tempus

...a series A round, bringing the total to $46 million. New investors Adams Street Partners, Seroba Life Sciences...
BioCentury | Feb 11, 2017
Finance

Seroba’s shift

...the demand for biotech assets from potential buyers. The firm announced the first close of Seroba Life Sciences...
...in 2009 at €75 million ($96.8 million). O’Connell declined to disclose returns. - Virginia Li Virginia Li Seroba Life Sciences...
BioCentury | Feb 10, 2017
Financial News

Seroba Life Sciences financial update

...Seroba Life Sciences (Dublin, Ireland) announced the first close of its third fund, Seroba Life Sciences Fund III...
...other life sciences companies in Ireland, the U.K. and elsewhere in Europe. Seroba Life Sciences, Dublin, Ireland Alex Himes Seroba Life Sciences...
BioCentury | Feb 10, 2017
Financial News

Prexton completes venture financing

...€29 million ($31.2 million) in a series B round co-led by Forbion Capital Partners and Seroba Life Sciences...
Items per page:
1 - 10 of 12